AbL Diagnostics Financials

ABLD Stock   2.40  0.10  4.00%   
We suggest to use analysis of AbL Diagnostics SA fundamentals to see if markets are now mispricing the company. We were able to analyze nineteen available fundamental indicators for AbL Diagnostics SA, which can be compared to its peers. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of AbL Diagnostics to be traded at 2.3 in 90 days.
  
Understanding current and past AbL Diagnostics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AbL Diagnostics' financial statements are interrelated, with each one affecting the others. For example, an increase in AbL Diagnostics' assets may result in an increase in income on the income statement.
Please note, the presentation of AbL Diagnostics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AbL Diagnostics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AbL Diagnostics' management manipulating its earnings.
Foreign Associate
  USA
InstrumentFrance Stock View All
ExchangeEuronext Paris
ISINFR001400AHX6
Business Address42 rue Olivier
SectorIndustrials
IndustryRailroads
BenchmarkDow Jones Industrial
Websitewww.fauvet-girel.fr
Phone33 1 45 061 574
You should never invest in AbL Diagnostics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AbL Stock, because this is throwing your money away. Analyzing the key information contained in AbL Diagnostics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

AbL Diagnostics Key Financial Ratios

AbL Diagnostics' financial ratios allow both analysts and investors to convert raw data from AbL Diagnostics' financial statements into concise, actionable information that can be used to evaluate the performance of AbL Diagnostics over time and compare it to other companies across industries.

AbL Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AbL Diagnostics's current stock value. Our valuation model uses many indicators to compare AbL Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AbL Diagnostics competition to find correlations between indicators driving AbL Diagnostics's intrinsic value. More Info.
AbL Diagnostics SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AbL Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AbL Diagnostics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

AbL Diagnostics SA Systematic Risk

AbL Diagnostics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AbL Diagnostics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on AbL Diagnostics SA correlated with the market. If Beta is less than 0 AbL Diagnostics generally moves in the opposite direction as compared to the market. If AbL Diagnostics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AbL Diagnostics SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AbL Diagnostics is generally in the same direction as the market. If Beta > 1 AbL Diagnostics moves generally in the same direction as, but more than the movement of the benchmark.

AbL Diagnostics December 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of AbL Diagnostics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AbL Diagnostics SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of AbL Diagnostics SA based on widely used predictive technical indicators. In general, we focus on analyzing AbL Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AbL Diagnostics's daily price indicators and compare them against related drivers.

Complementary Tools for AbL Stock analysis

When running AbL Diagnostics' price analysis, check to measure AbL Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbL Diagnostics is operating at the current time. Most of AbL Diagnostics' value examination focuses on studying past and present price action to predict the probability of AbL Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbL Diagnostics' price. Additionally, you may evaluate how the addition of AbL Diagnostics to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope